Resultados de la búsqueda 351-360 of 1235 for total t4
Additionally, to compare the effectiveness of axicabtagene ciloleucel versus SOCT, as measured by progression-free survival (PFS) and overall survival (OS).
The overall goal of PPMI is to identify markers of disease progression ... total toxicity profile. The purpose of phase 2 of this trial is to evaluate ...
The purpose of this study is to systematically and prospectively record accurate and complete ... overall, 7% of patients develop CHF (median follow-up 8.5 years) ...
The purpose of this study is to determine the safety and feasibility of complete outpatient blinatumomab administration for subjects with minimal residual ...
A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.
The purpose of this study is to evaluate the effectiveness of cilta-cel OOS based on overall response of partial response (PR) or better (overall response rate, ...
... total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...
Patients will be followed per standard of care during ICI treatment and continue VSL#3 for 12 more weeks while on ICI. Patients will complete dietary ...
Once this is complete treatment will be directed based on the genomic signature of patients individual tumor. I-SPY TRIAL: Neoadjuvant and Personalized Adaptive ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?